[ad_1]

Company Logo

Dublin, June 28, 2022 (GLOBE NEWSWIRE) — The “Cancer Vaccines: Analytical Tool” report has been added to ResearchAndMarkets.com’s providing.

Cancer Vaccines: Analytical Tool is the should have handbook for any enterprise developer, BI/CI operative or scientific developer who must be on high of this sizzling and fast-paced space of immune-oncology.

This distinctive product is actually the one instrument of its form and is designed to provide you a aggressive edge in your most cancers vaccine drug surveillance and intelligence, permitting you to energy your determination making and advance your personal pursuits.

Your Cancer Vaccines: Analytical Tool covers greater than 372 firms plus companions who’re immediately creating 767 most cancers vaccine medication the place of 482 are in energetic improvement in most cancers throughout 211 completely different targets.

Any knowledge and/or evaluation from the Analytical Tool is yours to maintain and knowledge/graphs/tables may be simply exported into Excel/PDF and varied graphic codecs for mixing with your personal proprietary data.

Keeping you “In the know”

Simply put, our mission is to gas your data of immune-oncology, to make you the primary to find out about very early applied sciences and startups, rising scientific trial outcomes, drug approvals and the ever-changing aggressive panorama.

Cancer Vaccines: Analytical Tool achieves this by constantly scanning improvement in most cancers vaccine and reporting:

Deals & Collaborations

New applied sciences/medication (rising from patents, grants, abstracts (see Conference Coverage) and so on.)

Funding/Grants/IPOs

Filings & Approvals

Latest Clinical Trial Development & Results

Newly launched scientific trials

Conference Coverage of the world’s twelve main conferences in oncology*

Quarterly & Annual Reporting

This places you accountable for most, if not all, day-to-day developments in your discipline whereas additionally benefiting from some of the complete industrial pipeline evaluate & aggressive evaluation instruments out there in the marketplace immediately!

Identify, prioritize, and lead scientific evaluation of oncology alternatives and competitors by a number of elements akin to:

Story continues

Emerging Technologies

Target Novelty

Recent Funding

Early & Late Stage Pipeline

Biomarker/Companion Diagnostic Development (featured beneath)

Entered Deals & Alliances

Conference surveillance of world main most cancers conferences (featured beneath)

Combination Therapy Choices (featured beneath)

Outcome of Clinical Trials

Indication Selection & Expansion Choices

Drug Repositioning Opportunities

Let our experience be just right for you

With a easy level and click on interface you’ll be able to navigate the atmosphere of present improvement, drill down into particular areas akin to ongoing mixture trials, biomarker evaluation, chosen scientific abstracts and so on. and generate drug profiles, drug goal profiles and firm profiles (together with Business Development & Licensing contacts). Any evaluation generated by you is filled with presentation-ready graphs and tables to make use of in your studies and shows.

Your key to entry improvement on the world-leading most cancers conferences

The Cancer Vaccines: Analytical Tool is constantly up to date in keeping with twelve of the world’s most influential conferences in oncology (AACR, ASCO, ASGCT, ASH, CMIT, EHA, EORTC-NCI-AACR, ESMO, SITC and BIO (International, Europe and Asia). If you aren’t in a position to attend any of the convention(s) in individual, this Analytical Tool ensures that you’re not lacking out on the vital take residence messages you must find out about.

Run mixture remedy evaluation like no different

The Cancer Vaccines: Analytical Tool delivers complete mixture remedy evaluation, permitting you to investigate mixture therapies from a number of views; from a single drug to just about any cross part of oncology medication of curiosity.

Unparalleled biomarker surveillance

We additionally present an excellent oncology scientific biomarker surveillance & evaluation, highlighting scientific phenotyping and affected person stratification in trials. This evaluation relies on our monitoring of the presence and utilization of greater than 1,000 biomarkers throughout tens of hundreds of most cancers scientific trials.

Support and inspiration at your finger-tips
You even have entry to an amazing collection of How-to Training Videos displaying greatest apply approaches to points akin to aggressive pipeline evaluation proper by way of to many actual world case examples put ahead by different customers of our Analytical Tools.

A instrument to develop with and preserve you knowledgeable

Unlike a static report which simply represents a specific snapshot in time, all the Analytical Tools include one yr of on-line entry to twice-weekly updates in each contents and options, pipeline alerts and on-line help and so on. You can select to resume your entry to those updates and help on a yearly foundation or go over to our trade main full service platform masking all oncology drug improvement, 1stOncology.

For extra details about this report go to https://www.researchandmarkets.com/r/xy216b

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

[ad_2]

Source link

#Gain #Competitive #Edge #Cancer #Vaccine #Drug #Surveillance #Intelligence

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published.